CROI 2019 Program and Conference Information

Poster Sessions

479 A QUANTITATIVE APPROACH TO EVALUATE ARV PROXIMITY TO VIRUS AND CELLS IN LYMPHNODES Elias Rosen, Claire Deleage, Yuri Fedoriw, Jacob D. Estes, Angela Kashuba Poster P-H1 NOVEL ANTIRETROVIRAL AGENTS AND FORMULATIONS Poster Hall - 4EF 2:30 PM - 4:00 PM 480 GS-6207, A POTENT AND SELECTIVE FIRST-IN-CLASS LONG- ACTING HIV-1 CAPSID INHIBITOR Stephen R. Yant, Andrew Mulato, George Stepan, Armando G. Villasenor, Debi Jin, Nicolas A. Margot, Shekeba Ahmadyar, Renee R. Ram, John R. Somoza, Eric Singer, Melanie Wong, Yili Xu, John O. Link, Tomas Cihlar, Winston C. Tse MK-8591 POTENCY AND PK PROVIDE HIGH INHIBITORY QUOTIENTS AT LOWDOSES QD AND QW Jay Grobler, Kerry Fillgrove, Daria Hazuda, Qian Huang, Ming-Tain Lai, Randolph P. Matthews, Deanne J. Rudd, Ryan Vargo FAVOURABLE OUTCOME OF INVITRO SELECTIONSWITHNOVEL NRTI PRODRUG GS-9131 Ruxandra-Ilinca Ibanescu, Maureen Oliveira, Bonnie Spira, Jean-Pierre Routy, Bluma G. Brenner, for the Montreal Primary HIV (PHI) Cohort Study Group 481 482 LONG-TERMSAFETY & EFFICACY OF FOSTEMSAVIR IN TREATMENT-EXPERIENCED HIV PARTICIPANTS Melanie Thompson, Fernando Mendo Urbina, Gulam Latiff, Sandra Trevino Perez, Edwin DeJesus, Natalia Zakharova, Marcelo Martins, Johannes Bogner, Li Yi, Amy Pierce, Shiven Chabria, Peter Ackerman, Cyril Llamoso, Max Lataillade, for the 205889 Investigative Study Team ACTIVITY OF ECD4-IG AGAINST CCR5 ANTAGONIST-RESISTANT HIV-1 Zixin Hu, Phillip Tomezsko, Matthew Gardner, Michael Farzan, Athe Tsibris, Daniel R. Kuritzkes IBALIZUMAB:WEEK 96 DATA Brinda Emu, Jay Lalezari, Princy Kumar, Steven Weinheimer, Stanley Lewis, Brandon Cash, Zvi Cohen PRO 140 SC: LONG-ACTING, SINGLE-AGENTMAINTENANCE THERAPY FOR HIV-1 INFECTION Kush Dhody, Kazem Kazempour, Nader Pourhassan, Paul J. Maddon IN SILICO SIMULATION OF LONG-ACTING TENOFOVIR ALAFENAMIDE SUBCUTANEOUS IMPLANT Rajith Kumar Reddy Rajoli, Zach Demkovich, Ariane van der Straten, Charles W. Flexner, Andrew Owen, Marco Siccardi 484 485 486 487 LONG-ACTING EMTRICITABINE PRODRUGS PROVIDE PROTECTION FROMHIV INFECTION INVIVO Paul Curley, James J. Hobson, Neill Liptrott, Amer Al-Khouja, David Meyers, Caren Freel Meyers, Charles W. Flexner, Marco Siccardi, Steve Rannard, Larisa Y. Poluektova, Andrew Owen PRODRUGS EXTEND THE HALF LIFE AND POTENCY OF CABOTEGRAVIR Tanmay A. Kulkarni, Aditya N. Bade, Brady J. Sillman, Bhagya Dyavar Shetty, Melinda Wojtkiewicz, JoEllyn McMillan, Benson Edagwa, Howard E. Gendelman 489 483 488

Poster Sessions • Thursday

CROI 2019 139